Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating lenalidomide for painful lumbar radiculopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Radiculopathy

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Celgene Corporation | Conditions: Radiculopathy | Phase 2, Phase 3 | Status: COMPLETED